Skip to main content
. Author manuscript; available in PMC: 2018 Feb 28.
Published in final edited form as: Leuk Lymphoma. 2016 Jun 23;58(2):288–297. doi: 10.1080/10428194.2016.1190970

Table 1.

Patients, Disease, Graft and Conditioning

N 39
Median Age (range) 66 (18-72)
Male/female 19/20
Median Weight 80 (41-118)
Disease
DRI Intermediate/High/Very High 22/15/2
KPS ≤ 80 vs >90-100 14/25
HCTCI >3 vs ≤ 3 >3 15/24
Haplo Graft
HLA match 4-5/8 vs 6-7/8 35 vs 4
DSA present 4
UCB Graft
CD34 Dose collected median-range (×105.kg) .66 (.13–4.3)
CBU viability at infusion 97% (88–99)
TNC infused (×107.kg) 2.1 (0.8–3.9)
HLA match 4-5-6/8 vs 7-8/8 16 vs 23
DSA present 6
Flu Mel ATG vs Flu MEL ATG Low DBI 33 vs 6